The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Solid form screening – A review
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wold, S., Esbensen, K., & Geladi, P. (1987) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/0169-7439(87)80084-9 · Cited by 11,606
DREIDING: a generic force field for molecular simulations
Mayo, S. L., Olafson, B. D., & Goddard, W. A. (1990) · The Journal of Physical Chemistry · doi:10.1021/j100389a010 · Cited by 6,585
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Handbook of Chemometrics and Qualimetrics: Part A
(1998) · Data Handling in Science and Technology · doi:10.1016/s0922-3487(97)x8000-1 · Cited by 2,027
Characteristics and Significance of the Amorphous State in Pharmaceutical Systems
Hancock, B. C., & Zografi, G. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9601896 · Cited by 1,922
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
Amorphous pharmaceutical solids: preparation, characterization and stabilization
Yu, L. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00098-9 · Cited by 1,405
What is the True Solubility Advantage for Amorphous Pharmaceuticals?
Hancock, B. C., & Parks, M. (2000) · Pharmaceutical Research · doi:10.1023/a:1007516718048 · Cited by 1,358
Polymorphism in Molecular Crystals
Bernstein, J. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199236565.001.0001 · Cited by 1,346
Polymorphism in Pharmaceutical Solids
(2018) · CRC Press eBooks · doi:10.3109/9781420073225 · Cited by 1,099
Solid state chemistry of drugs
Byrn, S. R. (1982) · Medical Entomology and Zoology · Cited by 1,086
Vishweshwar, P., McMahon, J. A., Bis, J. A., & Zaworotko, M. J. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20578 · Cited by 968
Pharmaceutical Applications of Polymorphism
Haleblian, J., & McCrone, W. (1969) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600580802 · Cited by 855
Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development
Chemburkar, S. R., Bauer, J., Deming, K., Spiwek, H., Patel, K., Morris, J., Henry, R., Spanton, S., Dziki, W., Porter, W., et al. (2000) · Organic Process Research & Development · doi:10.1021/op000023y · Cited by 687
Drug polymorphism and dosage form design: a practical perspective
Singhal, D. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.008 · Cited by 596
Crystal structures of drugs: advances in determination, prediction and engineering
Datta, S., & Grant, D. J. W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1280 · Cited by 583
Analysis of organic polymorphs. A review
Threlfall, T. L. (1995) · The Analyst · doi:10.1039/an9952002435 · Cited by 552
Handbook of Chemometrics and Qualimetrics, Part B
Ziegel, E. R. (2000) · Technometrics · doi:10.1080/00401706.2000.10486023 · Cited by 529
Gu, C.-H., Li, H., Gandhi, R. B., & Raghavan, K. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.06.021 · Cited by 463
Innovation Policy and the Economy
(2007) · The MIT Press eBooks · doi:10.7551/mitpress/3788.001.0001 · Cited by 455
Impact of solid state properties on developability assessment of drug candidates
Huang, L. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.007 · Cited by 438
A third blind test of crystal structure prediction
Day, G. M., Motherwell, W. D. S., Ammon, H. L., Boerrigter, S. X. M., Della Valle, R. G., Venuti, E., Dzyabchenko, A., Dunitz, J. D., Schweizer, B., van Eijck, B. P., et al. (2005) · Acta Crystallographica Section B Structural Science · doi:10.1107/s0108768105016563 · Cited by 430
Molecular Recognition in Organic Crystals: Directed Intermolecular Bonds or Nonlocalized Bonding?
Dunitz, J. D., & Gavezzotti, A. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200460157 · Cited by 417
Physical Characterization of Pharmaceutical Solids
Brittain, H. G., Bogdanowich, S. J., Bugay, D. E., DeVincentis, J., Lewen, G., & Newman, A. W. (1991) · Pharmaceutical Research · doi:10.1023/a:1015888520352 · Cited by 344
First-principles and direct design approaches for the control of pharmaceutical crystallization
Fujiwara, M., Nagy, Z. K., Chew, J. W., & Braatz, R. D. (2005) · Journal of Process Control · doi:10.1016/j.jprocont.2004.08.003 · Cited by 344
Polymorphism in Molecular Crystals: Stabilization of a Metastable Form by Conformational Mimicry
Davey, R. J., Blagden, N., Potts, G. D., & Docherty, R. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9626345 · Cited by 339
Applications of process analytical technology to crystallization processes
Yu, L. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.012 · Cited by 323
Amorphous Drug Delivery Systems: Molecular Aspects, Design, and Performance
Kaushal, A. M., Gupta, P., & Bansal, A. K. (2004) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v21.i3.10 · Cited by 312
Drugs as materials: valuing physical form in drug discovery
Gardner, C. R., Walsh, C. T., & Almarsson, Ö. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1550 · Cited by 284
Chemical reactivity in solid-state pharmaceuticals: formulation implications
Byrn, S. R., Xu, W., & Newman, A. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00102-8 · Cited by 259
Controlling factor of polymorphism in crystallization process
Kitamura, M. (2002) · Journal of Crystal Growth · doi:10.1016/s0022-0248(01)02277-1 · Cited by 235
Raw, A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.011 · Cited by 206
The relaxation of molecular crystal structures using a distributed multipole electrostatic model
Willock, D. J., Price, S. L., Leslie, M., & Catlow, C. R. A. (1995) · Journal of Computational Chemistry · doi:10.1002/jcc.540160511 · Cited by 161
Day, G. M., Zeitler, J. A., Jones, W., Rades, T., & Taday, P. F. (2006) · The Journal of Physical Chemistry B · doi:10.1021/jp055439y · Cited by 159
The Bioinequivalence of Carbamazepine Tablets with a History of Clinical Failures
Meyer, M. C., Straughn, A. B., Jarvi, E. J., Wood, G. C., Pelsor, F. R., & Shah, V. P. (1992) · Pharmaceutical Research · doi:10.1023/a:1015872626887 · Cited by 157
Heinz, A., Savolainen, M., Rades, T., & Strachan, C. J. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.07.003 · Cited by 127
Polymorphism in generic drug product development
Snider, D. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.010 · Cited by 119
349. The vapour pressure and lattice energy of some aromatic ring compounds
Bradley, R. S., & Cleasby, T. G. (1953) · Journal of the Chemical Society (Resumed) · doi:10.1039/jr9530001690 · Cited by 108
Williams, D. E. (2001) · Journal of Computational Chemistry · doi:10.1002/jcc.1074.abs · Cited by 103
Pratiwi, D., Fawcett, J. P., Gordon, K. C., et al. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00113-3 · Cited by 102
Self-citationChilds, S. L., Chyall, L. J., Dunlap, J. T., Coates, D. A., Stahly, B. C., & Stahly, G. P. (2004) · Crystal Growth & Design · doi:10.1021/cg034243p · Cited by 100
Energy Minimization of Crystal Structures Containing Flexible Molecules
Karamertzanis, P. G., & Price, S. L. (2006) · Journal of Chemical Theory and Computation · doi:10.1021/ct600111s · Cited by 87
The polymorphism of progesterone: Stabilization of a ‘disappearing’ polymorph by co‐crystallization
Lancaster, R. W., Karamertzanis, P. G., Hulme, A. T., Tocher, D. A., Lewis, T. C., & Price, S. L. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20983 · Cited by 83
Computational analysis of crystallization trials
Spraggon, G., Lesley, S. A., Kreusch, A., & Priestle, J. P. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016840 · Cited by 64
Williams, D. E. (1999) · Journal of Molecular Structure · doi:10.1016/s0022-2860(99)00092-7 · Cited by 63
Multivariate data analysis as a fast tool in evaluation of solid state phenomena
Jørgensen, A. C., Miroshnyk, I., Karjalainen, M., Jouppila, K., Siiriä, S.-M., Antikainen, O. K., & Rantanen, J. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20573 · Cited by 49
Self-citationBraga, J. W. B., & Poppi, R. J. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20109 · Cited by 49
DRIFT-IR for quantitative characterization of polymorphic composition of sulfathiazole
Pöllänen, K., Häkkinen, A., Huhtanen, M., Рейникайнен, С.-П., Karjalainen, M., Rantanen, J., Louhi‐Kultanen, M., & Nyström, L. (2005) · Analytica Chimica Acta · doi:10.1016/j.aca.2005.02.074 · Cited by 36
Self-citationBro, R., & Jakobsen, M. (2002) · Journal of Chemometrics · doi:10.1002/cem.722 · Cited by 28
Racemic progesterone: predicted in silico and produced in the solid state
Lancaster, R. W., Karamertzanis, P. G., Hulme, A. T., Tocher, D. A., Covey, D. F., & Price, S. L. (2006) · Chemical Communications · doi:10.1039/b611599c · Cited by 18
Cited by
X-Ray Diffraction: Instrumentation and Applications
Bunaciu, A. A., Udriştioiu, E. G., & Aboul-Enein, H. Y. (2015) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2014.949616 · Cited by 953
De Beer, T., Burggraeve, A., Fonteyne, M., Saerens, L., Remon, J. P., & Vervaet, C. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.012 · Cited by 559
The Future of Pharmaceutical Manufacturing Sciences
Rantanen, J., & Khinast, J. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24594 · Cited by 442
Self-citationPharmaceutical solvates, hydrates and amorphous forms: A special emphasis on cocrystals
Healy, A. M., Worku, Z. A., Kumar, D., & Madi, A. M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.03.002 · Cited by 370
Pharmaceutical cocrystals: from serendipity to design to application
Kavanagh, O. N., Croker, D. M., Walker, G. M., & Zaworotko, M. J. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.023 · Cited by 323
Metadata
- Authors
- AALTONEN, J., ALLESO, M., MIRZA, S., KORADIA, V, GORDON, K., & RANTANEN, J.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 71
- Issue
- 1
- Pages
- 23-37
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W2086736722
- Cited by
- 276
- References
- 50
- FWCI
- 6.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.